Niagen Bioscience

NAGENasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$166.313 M

$2.10 -16.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Niagen Bioscience (NAGE) has a market capitalization of $166.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$129.4M

#2413 by revenue

Earnings

$17.4M

#1903 by earnings

Shares outstanding

79,196,903

Latest filing cover page

P/E ratio

9.6

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#15Glass House BrandsGLAS$200.6M
#16MediWoundMDWD$174.9M
#17Niagen BioscienceNAGE$166.3M
#18Ispire TechnologyISPR$82.3M
#19Fitlife BrandsFTLF$75.1M

What if Niagen Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$356,540.13

Per share 169,781× higher

Bitcoin $1.53T

$19,291.77

Per share 9,187× higher

Apple $5.02T

$63,333.07

Per share 30,159× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Niagen Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.